“…Therefore, enantioenriched prodrugs can be, in theory, hydrolyzed either faster or slower by enzymes, leading to a higher degree of metabolism manipulation. In the past decade, a number of asymmetric phthalide syntheses using an organometallic complex, organocatalyst, , and enzyme catalysis − have been reported, with some of the phthalide products exhibiting remarkable biological properties. However, the synthesis of chiral prodrugs, phthalidyl esters included, has not drawn enough attention from both academia and industry, mainly due to the lack of mature methodology and high R&D costs. − …”